絞り込み

16639

広告

Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis.

著者 Simpson EL , James MM , Hamilton J , Wong R , Gittoes N , Selby P , Davis S
Bone.2019 Oct 15 ; ():115081.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (21view , 0users)

Full Text Sources

Miscellaneous

To determine the clinical effectiveness of denosumab (DEN), raloxifene (RLX), romosozumab (ROMO) and teriparatide (TPTD), within their licensed (or anticipated licensed) indications, for the treatment of osteoporosis.
PMID: 31626995 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード